3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
venetoclax
30
Rituximab
26
ibrutinib
22
acalabrutinib
22
Cyclophosphamide
22
Specimen Handling
20
obinutuzumab
17
Biopsy
15
fludarabine
13
zanubrutinib
11
pirtobrutinib
10
fludarabine phosphate
10
Magnetic Resonance Spectroscopy
9
Bendamustine Hydrochloride
9
Lenalidomide
7
CT-P10
7
idelalisib
6
Whole-Body Irradiation
6
Mycophenolic Acid
6
ARQ531
6
Cyclosporine
5
Vincristine
4
Sirolimus
4
Prednisone
4
Peripheral Blood Stem Cell Transplantation
4
Doxorubicin
4
Blood Component Removal
4
pembrolizumab
3
Tacrolimus
3
Stem Cell Transplantation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
2C4 antibody
×
90 days
×
Clear all
No trials found.